Ex Vivo Analysis of Cell Differentiation, Oxidative Stress, Inflammation, and DNA Damage on Cutaneous Field Cancerization.
Lara CamilloElisa ZavattaroFederica VeroneseLaura Cristina GironiOttavio CremonaPaola SavoiaPublished in: International journal of molecular sciences (2024)
Cutaneous field cancerization (CFC) refers to a skin region containing mutated cells' clones, predominantly arising from chronic exposure to ultraviolet radiation (UVR), which exhibits an elevated risk of developing precancerous and neoplastic lesions. Despite extensive research, many molecular aspects of CFC still need to be better understood. In this study, we conducted ex vivo assessment of cell differentiation, oxidative stress, inflammation, and DNA damage in CFC samples. We collected perilesional skin from 41 patients with skin cancer and non-photoexposed skin from 25 healthy control individuals. These biopsies were either paraffin-embedded for indirect immunofluorescence and immunohistochemistry stain or processed for proteins and mRNA extraction from the epidermidis. Our findings indicate a downregulation of p53 expression and an upregulation of Ki67 and p16 in CFC tissues. Additionally, there were alterations in keratinocyte differentiation markers, disrupted cell differentiation, increased expression of iNOS and proinflammatory cytokines IL-6 and IL-8, along with evidence of oxidative DNA damage. Collectively, our results suggest that despite its outwardly normal appearance, CFC tissue shows early signs of DNA damage, an active inflammatory state, oxidative stress, abnormal cell proliferation and differentiation.
Keyphrases
- oxidative stress
- dna damage
- induced apoptosis
- cell proliferation
- poor prognosis
- dna repair
- diabetic rats
- soft tissue
- ischemia reperfusion injury
- skin cancer
- wound healing
- binding protein
- long non coding rna
- gene expression
- signaling pathway
- cell cycle arrest
- squamous cell carcinoma
- neoadjuvant chemotherapy
- radiation therapy
- endoplasmic reticulum stress
- resting state
- drug induced
- staphylococcus aureus
- clinical evaluation